Kazuhiro Aiba
- Molecular Biology top 10%
- Biomedical Engineering
- Surgery
- Genetics
- Cellular and Molecular Neuroscience top 10%
- Co-authors
- Minoru S.H. KoAlexei A. SharovNorio NakatsujiLioudmila V. SharovaItsunari MinamiRyo MatobaYulan PiaoMark G. Carter
- Topics
- Pluripotent Stem Cells Research (17 papers)Cancer Treatment and Pharmacology (11 papers)Colorectal Cancer Treatments and Studies (7 papers)
- Partner nations
- JapanUnited StatesArgentina
In The Last Decade
Kazuhiro Aiba
53 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 1.2k
- Biomedical Engineering 206
- Surgery 191
- Genetics 175
- Cellular and Molecular Neuroscience 131
Countries citing papers authored by Kazuhiro Aiba
This map shows the geographic impact of Kazuhiro Aiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuhiro Aiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuhiro Aiba more than expected).
Fields of papers citing papers by Kazuhiro Aiba
This network shows the impact of papers produced by Kazuhiro Aiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuhiro Aiba. The network helps show where Kazuhiro Aiba may publish in the future.
Co-authorship network of co-authors of Kazuhiro Aiba
This figure shows the co-authorship network connecting the top 25 collaborators of Kazuhiro Aiba. A scholar is included among the top collaborators of Kazuhiro Aiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuhiro Aiba. Kazuhiro Aiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 29 | |
| 2 | 11 | |
| 3 | 109 | |
| 4 | 34 | |
| 5 | 1 | |
| 6 | 14 | |
| 7 | 81 | |
| 8 | 135 | |
| 9 | 11 | |
| 10 | 65 | |
| 11 | 39 | |
| 12 | 4 | |
| 13 | 6 | |
| 14 | Intrahepatic interleukin-2 with chemotherapy for unresectable liver metastases: a randomized multicenter trial. | 10 |
| 15 | 3 | |
| 16 | 20 | |
| 17 | [Phase I and pharmacokinetic study of SM-5887 by 5-day schedule]. | 3 |
| 18 | 7 | |
| 19 | 7 | |
| 20 | [A phase I study of carboplatin]. | 5 |
About Kazuhiro Aiba
Kazuhiro Aiba is a scholar working on Oncology, Developmental Neuroscience and Genetics, having authored 56 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (17 papers), Cancer Treatment and Pharmacology (11 papers) and Colorectal Cancer Treatments and Studies (7 papers). The work is most often cited by research in Molecular Biology (1.2k citations), Developmental Neuroscience (59 citations) and Aging (21 citations). Kazuhiro Aiba has collaborated with scholars based in Japan, United States and Argentina. Frequent co-authors include Minoru S.H. Ko, Alexei A. Sharov, Norio Nakatsuji, Lioudmila V. Sharova, Itsunari Minami, Ryo Matoba, Yulan Piao, Mark G. Carter, John E. Heuser and Tomomi G. Otsuji. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.